ISSN 1725-2423 doi:10.3000/17252423.C_2011.234.eng |
||
Official Journal of the European Union |
C 234 |
|
English edition |
Information and Notices |
Volume 54 |
Notice No |
Contents |
page |
|
II Information |
|
|
INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
European Commission |
|
2011/C 234/01 |
Non-opposition to a notified concentration (Case COMP/M.6297 — Sealed Air/DHI) ( 1 ) |
|
2011/C 234/02 |
Non-opposition to a notified concentration (Case COMP/M.6189 — Imerys/Rio Tinto Talc Business) ( 1 ) |
|
2011/C 234/03 |
Non-opposition to a notified concentration (Case COMP/M.6322 — Carlyle/RAC) ( 1 ) |
|
2011/C 234/04 |
Initiation of proceedings (Case COMP/M.6166 — Deutsche Börse/NYSE Euronext) ( 1 ) |
|
|
IV Notices |
|
|
NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
European Commission |
|
2011/C 234/05 |
||
2011/C 234/06 |
Commission Decision of 9 August 2011 on appointing members of the Committee for Orphan Medicinal Products ( 1 ) |
|
|
V Announcements |
|
|
PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
|
|
European Commission |
|
2011/C 234/07 |
Prior notification of a concentration (Case COMP/M.6210 — VFE Commerce/CDC/JV) — Candidate case for simplified procedure ( 1 ) |
|
|
|
|
(1) Text with EEA relevance |
EN |
|
II Information
INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES
European Commission
10.8.2011 |
EN |
Official Journal of the European Union |
C 234/1 |
Non-opposition to a notified concentration
(Case COMP/M.6297 — Sealed Air/DHI)
(Text with EEA relevance)
2011/C 234/01
On 2 August 2011, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:
— |
in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
— |
in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32011M6297. EUR-Lex is the on-line access to the European law. |
10.8.2011 |
EN |
Official Journal of the European Union |
C 234/1 |
Non-opposition to a notified concentration
(Case COMP/M.6189 — Imerys/Rio Tinto Talc Business)
(Text with EEA relevance)
2011/C 234/02
On 7 July 2011, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:
— |
in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
— |
in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32011M6189. EUR-Lex is the on-line access to the European law. |
10.8.2011 |
EN |
Official Journal of the European Union |
C 234/2 |
Non-opposition to a notified concentration
(Case COMP/M.6322 — Carlyle/RAC)
(Text with EEA relevance)
2011/C 234/03
On 3 August 2011, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:
— |
in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
— |
in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32011M6322. EUR-Lex is the on-line access to the European law. |
10.8.2011 |
EN |
Official Journal of the European Union |
C 234/2 |
Initiation of proceedings
(Case COMP/M.6166 — Deutsche Börse/NYSE Euronext)
(Text with EEA relevance)
2011/C 234/04
On 4 August 2011, the Commission decided to initiate proceedings in the abovementioned case after finding that the notified concentration raises serious doubts as to its compatibility with the common market. The initiation of proceedings opens a second phase investigation with regard to the notified concentration, and is without prejudice to the final decision on the case. The decision is based on Article 6(1)(c) of Council Regulation (EC) No 139/2004.
The Commission invites interested third parties to submit their observations on the proposed concentration to the Commission.
In order to be fully taken into account in the procedure, observations should reach the Commission not later than 15 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301 / 22967244) or by post, under reference COMP/M.6166 — Deutsche Börse/NYSE Euronext, to the following address:
European Commission |
Directorate-General for Competition |
Merger Registry |
J-70 |
1049 Bruxelles/Brussel |
BELGIQUE/BELGIË |
IV Notices
NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES
European Commission
10.8.2011 |
EN |
Official Journal of the European Union |
C 234/3 |
Euro exchange rates (1)
9 August 2011
2011/C 234/05
1 euro =
|
Currency |
Exchange rate |
USD |
US dollar |
1,4267 |
JPY |
Japanese yen |
110,24 |
DKK |
Danish krone |
7,4497 |
GBP |
Pound sterling |
0,87310 |
SEK |
Swedish krona |
9,2127 |
CHF |
Swiss franc |
1,0594 |
ISK |
Iceland króna |
|
NOK |
Norwegian krone |
7,8295 |
BGN |
Bulgarian lev |
1,9558 |
CZK |
Czech koruna |
24,220 |
HUF |
Hungarian forint |
274,70 |
LTL |
Lithuanian litas |
3,4528 |
LVL |
Latvian lats |
0,7092 |
PLN |
Polish zloty |
4,0956 |
RON |
Romanian leu |
4,2625 |
TRY |
Turkish lira |
2,5164 |
AUD |
Australian dollar |
1,3990 |
CAD |
Canadian dollar |
1,4143 |
HKD |
Hong Kong dollar |
11,1401 |
NZD |
New Zealand dollar |
1,7329 |
SGD |
Singapore dollar |
1,7329 |
KRW |
South Korean won |
1 555,96 |
ZAR |
South African rand |
10,3710 |
CNY |
Chinese yuan renminbi |
9,1745 |
HRK |
Croatian kuna |
7,4550 |
IDR |
Indonesian rupiah |
12 251,94 |
MYR |
Malaysian ringgit |
4,3193 |
PHP |
Philippine peso |
60,611 |
RUB |
Russian rouble |
42,3780 |
THB |
Thai baht |
42,725 |
BRL |
Brazilian real |
2,3138 |
MXN |
Mexican peso |
17,7385 |
INR |
Indian rupee |
64,5010 |
(1) Source: reference exchange rate published by the ECB.
10.8.2011 |
EN |
Official Journal of the European Union |
C 234/4 |
COMMISSION DECISION
of 9 August 2011
on appointing members of the Committee for Orphan Medicinal Products
(Text with EEA relevance)
2011/C 234/06
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products (1), and in particular Article 4(3) thereof,
Having regard to the recommendation of the European Medicines Agency of 25 May 2011,
Whereas:
(1) |
The term of office of two members of the Committee for Orphan Medicinal Products which were appointed by the Commission on the recommendation from the European Medicines Agency expired in July 2011. |
(2) |
The European Medicines Agency has recommended the reappointment of these persons. |
(3) |
The members of the Committee shall be appointed for a period of three years starting on 1 September 2011, |
HAS DECIDED AS FOLLOWS:
Sole Article
On the recommendation of the European Medicines Agency, the following are hereby reappointed members of the Committee for Orphan Medicinal Products for a term of three years from 1 September 2011:
|
Prof. János BORVENDÉG |
|
Prof. Bruno SEPODES |
Done at Brussels, 9 August 2011.
For the Commission
John DALLI
Member of the Commission
V Announcements
PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY
European Commission
10.8.2011 |
EN |
Official Journal of the European Union |
C 234/5 |
Prior notification of a concentration
(Case COMP/M.6210 — VFE Commerce/CDC/JV)
Candidate case for simplified procedure
(Text with EEA relevance)
2011/C 234/07
1. |
On 2 August 2011, the Commission received notification pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 (1) of a proposed concentration by which the undertakings VFE Commerce, controlled by SNCF (France), and Caisse des Dépôts et Consignation (‘CDC’, France) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of a newly created company constituting a joint venture by way of purchase of shares. |
2. |
The business activities of the undertakings concerned are:
|
3. |
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
4. |
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6210 — VFE Commerce/CDC/JV, to the following address:
|
(1) OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).
(2) OJ C 56, 5.3.2005, p. 32 (‘Notice on a simplified procedure’).